Cantech Letter
Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Cantech Letter

Tap here to search for stock quotes, financial statistics and more.

or

  • All
  • Software
  • Cannabis
  • Fintech
  • Life Sciences
  • AI
  • Cleantech
  • Analysts
  • More
    • Hardware
    • Gaming
    • Interviews
    • Science
    • eCommerce
    • Lists and Data
    • Wireless
    • RIM
    • Stock Guides
Youtube

Pharma and Biotech

MDP stock
Analysts Pharma and Biotech mdp
Medexus Pharma will head even higher, says Raymond James

It’s been a wild ride for Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts, News, Analysts, Financials TSX:MDP) over the past couple of months, as the stock has more than doubled since June. But the fun ain’t over yet, according to Raymond James analyst Rahul Sarugaser, who in a Thursday report kept an “Outperform” rating on […]

Analysts Pharma and Biotech pmn
ProMIS Neuroscience heading to $26, says Leede Jones Gable

Leede Jones Gable analyst Douglas W. Loe reiterated a “Speculative Buy” rating on drug developer ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Charts, News, Analysts, Financials TSX:PMN) in a Monday report. Loe gave a positive review of recent clinical results that relate to ProMIS’ clinical program in treating neurodegenerative diseases such as Alzheimer’s.  ProMIS Neurosciences more […]

WELL Health
facebook Share twitter Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

MDP stock
Analysts Pharma and Biotech mdp

Medexus Pharma will head even higher, says Raymond James

August 11, 2023

It’s been a wild ride for Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts, Ne...

Analysts Pharma and Biotech pmn

ProMIS Neuroscience heading to $26, says Leede Jones Gable

July 18, 2023

Leede Jones Gable analyst Douglas W. Loe reiterated a “Speculative Buy” rating on drug developer...

MDP stock
Analysts Pharma and Biotech mdp

Medexus Pharma is a “compelling opportunity,” says Echelon

July 13, 2023

Echelon Capital Markets analyst Stefan Quenneville stayed bullish on Medexus Pharmaceuticals (Medexu...

Theratechnologies
Analysts Pharma and Biotech thtx

Theratechnologies is a Buy, says Research Capital

July 13, 2023

Canadian pharma stock Theratechnologies (Theratechnologies Stock Quote, Charts, News, Analysts, Fina...

Theratechnologies
Analysts Pharma and Biotech th

Theratechnologies has target slashed by Leede Jones Gable

July 13, 2023

Softer than expected quarterly revenue and more muted guidance from management are reasons to pare b...

Analysts Pharma and Biotech pbla

Panbela Therapeutics has a huge upside, says Roth

July 10, 2023

Roth Capital Partners analyst Johnathan Aschoff kept a “Buy” rating on biotech stock Panbela The...

Analysts Pharma and Biotech asln

Buy Aslan Pharma on the pullback, says Roth

July 10, 2023

It’s now day two in a selloff of Aslan Pharmaceuticals (Aslan Pharmaceuticals Stock Quote, Charts,...

Analysts Pharma and Biotech cph

Cipher Pharma is a Buy, says Leede Jones Gable

July 6, 2023

Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Charts, News, Analysts, Financials TSX:C...

DHT.UN stock
Analysts Pharma and Biotech dht.u

DRI Healthcare keeps Outperform rating with Raymond James

July 3, 2023

Investors will want to own a piece of DRI Healthcare Trust (DRI Healthcare Trust Stock Quote, Charts...

MDP stock
Analysts Pharma and Biotech mdp

Medexus Pharma is a Buy, says Roth

July 3, 2023

After reviewing the latest quarterly results from Medexus Pharmaceuticals (Medexus Pharmaceuticals S...

Sernova
Analysts Pharma and Biotech sva

Sernova is a Speculative Buy, says Leede Jones Gable

June 30, 2023

Leede Jones Gable provided an update on Thursday on Canadian regenerative medicine company Sernova (...

ATE stock
Analysts Pharma and Biotech ate

ATE stock has a 317 per cent upside, says Echelon

June 29, 2023

Investors searching for a high risk-tolerant stock in the biotech field should be thinking about Ant...

Analysts Pharma and Biotech gnta

Plenty of upside to biotech stock Genenta Science, says Roth

June 29, 2023

Roth Capital Partners analyst Kumaraguru Raja likes the look of biotech stock Genenta Science (Genen...

Analysts Pharma and Biotech pnt

Point Biopharma is heading to $13, says Raymond James

June 28, 2023

A new pair of research updates from Point Biopharma Global (Point Biopharma Global Stock Quote, Char...

Analysts Pharma and Biotech fusn

Fusion Pharmaceuticals has tons of upside, says Raymond James

June 28, 2023

Raymond James analyst Rahul Sarugaser maintained an “Outperform” rating on Fusion Pharmaceutical...

Analysts Pharma and Biotech arch

Arch Biopartners is a pass, says Raymond James

June 27, 2023

Shares of Arch Biopartners (Arch Biopartners Stock Quote, Charts, News, Analysts, Financials TSXV:AR...

Analysts Pharma and Biotech eprx

Eupraxia Pharmaceuticals is a Strong Buy, says Raymond James

June 27, 2023

More good news from Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Charts, News, An...

Analysts Pharma and Biotech mset

Mindset Pharma has tons of upside, says Echelon

June 26, 2023

Mindset Pharma (Mindset Pharma Stock Quote, Charts, News, Analysts, Financials CSE:MSET) is making m...

1 2 … 11 Next
facebook Share twitter Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
AC stock

Air Canada stock is a buy, Citi says

June 30, 2025
Tantalus Systems

Beacon raises price target on GRID to $5.50

June 26, 2025
BB stock

BlackBerry’s upcoming Q1 results might be better than expected, this analyst says

June 23, 2025
HITI stock

High Tide stock wins higher price target at Roth

June 18, 2025
CSU stock

Constellation Software has delivered a 36,000% return since its IPO. Is it still a buy?

May 29, 2025
  • 1 (604) 720-2684
    3860 Dollarton Hwy, North Vancouver, BC V7G 1A2
    Copyright © · Cantech Communications
    Financial Market Data powered by QuoteMedia © QuoteMedia, Inc.
    Data delayed 15 minutes unless otherwise indicated.

    • About
    • Stock Guides
    • Stock Wiki
    • Advertise
    • Terms and Conditions
    • Privacy Policy